Skip to main content

Table 1 Baseline patient characteristics

From: Long-term efficacy and safety of once-daily nevirapine in combination with tenofovir and emtricitabine in the treatment of HIV-infected patients: a 72-week prospective multicenter study (TENOR-Trial)

Total patients

70

Male

53

Female

17

Patients with VL > 100.000

12

Patients with VL < 50

27

Mean age (years)

41,7 (range 20-72 years)

ART naïve

32

ART experienced

38

Mean viral load (copies/ml)

76375

ART naïve

161789

ART experienced

4448

Mean CD4 count (per μl)

377

ART naïve

255

ART experienced

480